Basiliximab induction in patients receiving tacrolimus-based immunosuppressive regimens

Abstract

The use of basiliximab induction increased significantly in recent years based on its superior efficacy and excellent safety profile demonstrated in studies with cyclosporine-based immunosuppression. However, its clinical utility in patients receiving tacrolimus-based immunosuppressive regimens is still uncertain. We retrospectively reviewed data of 366 low… (More)
DOI: 10.1007/s11255-012-0298-6

Topics

6 Figures and Tables

Cite this paper

@article{SandesFreitas2012BasiliximabII, title={Basiliximab induction in patients receiving tacrolimus-based immunosuppressive regimens}, author={Tain{\'a} Veras de Sandes-Freitas and Cl{\'a}udia Rosso Felipe and Marcelo Franco and H{\'e}lio Tedesco-Silva and Jos{\'e} Osmar Medina-Pestana}, journal={International Urology and Nephrology}, year={2012}, volume={45}, pages={537-546} }